VEGFA and diabetic retinopathy: The MeSH terms were "Diabetic retinopathy" OR "Diabetes-related blindness"; "diabetic retinopathy prevalence" OR "risk factors; "development" OR "advancement"; "Pharmacological management of diabetic retinopathy" OR "Anti-VEGF therapy in diabetic retinopathy"; “Surgical management of diabetic retinopathy”; "Screening strategies for diabetic retinopathy" OR "telemedicine in diabetic retinopathy".